Clearer Guidelines Will Increase Choice and Help Lower Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to the U.S. Food and Drug Administration (FDA) announcing finalized guidance on interchangeable biologics: “This guidance marks great progress toward clearing barriers to investment in biologics that will help lower […]
Washington, D.C. – The House Energy & Commerce Subcommittee on Health held a hearing on the drug pricing supply chain Thursday. During the hearing, lawmakers from both sides of the aisle and several witnesses blasted Big Pharma for the industry’s anti-competitive tactics and price-gouging and praised bipartisan solutions to lower prices. Lawmakers also questioned the […]
Encourages House Leaders To Keep The Momentum Going Following Passage Of First Drug Pricing Bills of 116th Congress Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement following the passage of the first drug pricing bills considered by the full U.S. House of Representatives in the 116th Congress. Those bills, […]
Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of Legislative Actions To Deliver On Rising Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement encouraging members of the U.S. House of Representatives to pass the first two bills on drug pricing scheduled to […]
Greater List Price Transparency Will Help Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement following an announcement by the U.S. Department of Health and Human Services (HHS) that drug manufacturers will be required to disclose their pricing information in direct-to-consumer (DTC) advertising beginning in July: […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement commending the Senate Committee on the Judiciary for holding a hearing on the role of patent abuse in increasing prescription drug prices. Senators, from both sides of the aisle, grilled a witness representing large pharmaceutical manufacturers, expressed their commitment to action […]
Encourages Judiciary Committee To Hold Drug Makers Accountable, Seek Solutions To Spur Competition Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a Tuesday U.S. Senate Committee on the Judiciary hearing on the topic of prescription drug patents. “Big Pharma has gamed the patent system to crowd out […]
Nonpartisan Analysis Projects HHS Proposal A $187 Billion Budget-Buster That Would Hike Premiums On Seniors Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to the Congressional Budget Office’s (CBO) release of an analysis on the U.S. Department of Health and Human Services’ (HHS) proposed Rebate Rule: “The […]
Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday following earnings announcements from ten Big Pharma giants that showed they all surpassed profit forecasts for the first quarter of 2019. Drug maker GlaxoSmithKline (GSK) was the latest, announcing […]
GSK Completes The Sweep: Joins Fellow Drug Maker Giants In Beating Q1 Profit Forecasts One more pharmaceutical giant reported its first-quarter earnings today and surpassed expectations. The forecast-topping announcement completed a sweep for Big Pharma. Ten of the largest drug makers have now all bested earnings expectations for the first quarter of 2019. GlaxoSmithKline (GSK), […]